Lead exposure increases blood pressure by increasing angiotensinogen expression

Area of Science:

• Environmental Health
• Cardiovascular Physiology
• Molecular Biology

Background:

• Lead exposure is a known risk factor for hypertension.
• The renin-angiotensin system, particularly angiotensinogen (AGT), influences blood pressure regulation.
• The specific role of AGT in lead-induced hypertension requires further elucidation.

Purpose of the Study:

• To investigate the hypothesis that AGT expression levels or gene variants contribute to lead-induced hypertension.
• To analyze the association between lead exposure and AGT expression in cellular and human models.
• To examine the influence of AGT gene single nucleotide polymorphisms (SNPs) on lead-induced hypertension.

Main Methods:

• HEK293 cell models were used to assess AGT expression following lead exposure.
• Serum AGT levels were measured in lead-exposed individuals and controls.
• Genotyping of AGT SNPs (rs699 and rs4762) was performed in a case-control study.

Main Results:

• Lead exposure significantly increased AGT expression in HEK293 cells (P < 0.001).
• Lead-exposed individuals exhibited higher systolic and diastolic blood pressure (P < 0.001) and elevated serum AGT levels (P < 0.001) compared to controls.
• No significant association was found between AGT gene SNPs (rs699, rs4762) and lead exposure.

Conclusions:

• Increased AGT expression is implicated in the development of lead-induced hypertension.
• While specific AGT gene variants were not associated with lead exposure, altered AGT levels are a significant factor.
• These findings highlight AGT as a potential mediator in lead's hypertensive effects.